Beta-actin variant is necessary for Enterovirus 71 replication
Enterovirus 71 (EV71) is one of the main etiological agents of the Hand, Foot and Mouth Disease (HFMD) and has been known to cause fatal neurological complications such as herpangina, aseptic meningitis, poliomyelitis-like paralysis and encephalitis. EV71 is endemic in the Asia-Pacific region and ca...
| Main Authors: | Lui, Edmund Yan Long, Lin, Zhiyang, Lee, Jia Jun, Chow, Vincent Tak Kwong, Poh, Chit Laa *, Tan, Eng Lee |
|---|---|
| Format: | Article |
| Published: |
Elsevier
2013
|
| Subjects: | |
| Online Access: | http://eprints.sunway.edu.my/196/ |
Similar Items
Development of antivirals and vaccines against enterovirus 71 (EV-A71)
by: Poh, Chit Laa *
Published: (2018)
by: Poh, Chit Laa *
Published: (2018)
Flavonoids as antiviral agents for Enterovirus A71 (EV-A71)
by: Lalani, S.*, et al.
Published: (2020)
by: Lalani, S.*, et al.
Published: (2020)
Development of novel vaccines against Enterovirus-71
by: Yee, Isabel Pin Tsin *, et al.
Published: (2015)
by: Yee, Isabel Pin Tsin *, et al.
Published: (2015)
Functional insights into Silymarin as an antiviral agent against Enterovirus A71 (EV-A71)
by: Lalani, S.*, et al.
Published: (2021)
by: Lalani, S.*, et al.
Published: (2021)
Molecular docking of SP40 peptide towards cellular
receptors for enterovirus 71 (EV-A71)
by: Masomian, Malihe *, et al.
Published: (2021)
by: Masomian, Malihe *, et al.
Published: (2021)
Impact of genetic changes in the Enterovirus 71 genome on virulence
by: Poh, Chit Laa *, et al.
Published: (2019)
by: Poh, Chit Laa *, et al.
Published: (2019)
Inhibition of Enterovirus 71 (EV-71 infections by a novel
antiviral peptide derived from EV-71 capsid protein VP1
by: Tan, Chee Wah, et al.
Published: (2012)
by: Tan, Chee Wah, et al.
Published: (2012)
T Cell immunity to enterovirus 71 infection in humans and implications for vaccine development
by: Yee, Isabel Pin Tsin *, et al.
Published: (2018)
by: Yee, Isabel Pin Tsin *, et al.
Published: (2018)
Impact of genetic changes, pathogenicity and antigenicity on Enterovirus- A71 vaccine development
by: Yee, Isabel Pin Tsin *, et al.
Published: (2017)
by: Yee, Isabel Pin Tsin *, et al.
Published: (2017)
Development of novel miRNA-based vaccines and antivirals against Enterovirus 71
by: Yee, Isabel Pin Tsin *, et al.
Published: (2016)
by: Yee, Isabel Pin Tsin *, et al.
Published: (2016)
Identification of molecular determinants of cell culture growth characteristics of Enterovirus 71
by: Yee, Isabel Pin Tsin *, et al.
Published: (2016)
by: Yee, Isabel Pin Tsin *, et al.
Published: (2016)
Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor
by: Tan, Chee Wah, et al.
Published: (2013)
by: Tan, Chee Wah, et al.
Published: (2013)
In vitro evaluation of the antiviral activity of heparan sulfate mimetic compounds against Enterovirus 71
by: Pourianfar, Hamid Reza, et al.
Published: (2012)
by: Pourianfar, Hamid Reza, et al.
Published: (2012)
Cross-reactive neutralizing antibody epitopes against Enterovirus 71 identified by an in silico approach
by: Kirk, Kristin, et al.
Published: (2012)
by: Kirk, Kristin, et al.
Published: (2012)
Identification of mimotopes of human enterovirus 71
by: Yee, Siew Fung.
Published: (2007)
by: Yee, Siew Fung.
Published: (2007)
AIM2 Inflammasome-Mediated Pyroptosis in Enterovirus A71-Infected Neuronal Cells Restricts Viral Replication
by: Yogarajah, Thinesshwary, et al.
Published: (2017)
by: Yogarajah, Thinesshwary, et al.
Published: (2017)
Clinical features, diagnosis, and management of enterovirus 71
by: Ooi, Mong How, et al.
Published: (2010)
by: Ooi, Mong How, et al.
Published: (2010)
Virology, epidemiology, pathogenesis, and control of enterovirus 71.
by: Solomon, Tom, et al.
Published: (2010)
by: Solomon, Tom, et al.
Published: (2010)
Characterization of significant molecular determinants of virulence of Enterovirus 71 sub-genotype B4 in Rhabdomyosarcoma cells
by: Yee, Isabel Pin Tsin *, et al.
Published: (2017)
by: Yee, Isabel Pin Tsin *, et al.
Published: (2017)
Characterization of plaque variants and the involvement of Quasi-Species in a population of EV-A71
by: Mandary, M. B. *, et al.
Published: (2020)
by: Mandary, M. B. *, et al.
Published: (2020)
Development of live attenuated Enterovirus 71 vaccine strains that confer protection against lethal challenge in mice
by: Yee, Isabel Pin Tsin *, et al.
Published: (2019)
by: Yee, Isabel Pin Tsin *, et al.
Published: (2019)
Enterovirus A71 and coxsackievirus A16 show different replication kinetics in human neuronal and non-neuronal cell lines
by: Yogarajah, Thinesshwary, et al.
Published: (2016)
by: Yogarajah, Thinesshwary, et al.
Published: (2016)
Pluripotent human embryonic stem cell derived neural lineages for in vitro modelling of enterovirus 71 infection and therapy
by: Yap, May Shin *, et al.
Published: (2016)
by: Yap, May Shin *, et al.
Published: (2016)
Novel Multiplex Oligonucleotide-Conjugated Bead Suspension Array for Rapid Identification of Enterovirus 71 Subgenogroups
by: Wu, Y., et al.
Published: (2011)
by: Wu, Y., et al.
Published: (2011)
Development of a Deoxyribonucleic Acid Vaccine Against Enterovirus 71
by: Wong, Siew Tung
Published: (2005)
by: Wong, Siew Tung
Published: (2005)
Incorrect identification of recent Asian strains of Coxsackievirus A16 as human enterovirus 71: Improved primers for the specific detection of human enterovirus 71 by RT PCR
by: David, Perera, et al.
Published: (2004)
by: David, Perera, et al.
Published: (2004)
Recombinant human enterovirus 71 in hand, foot and mouth disease patients
by: Yoke, Fun Chan, et al.
Published: (2004)
by: Yoke, Fun Chan, et al.
Published: (2004)
Factors affecting expression and solubility of Enterovirus 71 VP1 protein
by: Ahmad Hafad, Fathimah Azzahroh
Published: (2016)
by: Ahmad Hafad, Fathimah Azzahroh
Published: (2016)
Enterovirus specific anti-peptide antibodies
by: Poh, Chit Laa *, et al.
Published: (2015)
by: Poh, Chit Laa *, et al.
Published: (2015)
The expression of recombinant
bacille calmette-guerin (rBCG) containing
VPI gene of enterovirus 71 (EV71)
by: Wey, Goh Kai
Published: (2008)
by: Wey, Goh Kai
Published: (2008)
A decade of sustained selection pressure on two surface sites of the VP1 protein of Enterovirus A71 suggests that immune evasion may be an indirect driver for virulence
by: Roberts, Ryan, et al.
Published: (2019)
by: Roberts, Ryan, et al.
Published: (2019)
Development of a diagnostic tool for the detection of antibodies against human enterovirus 71
by: Tan, Cheng Siang.
Published: (2004)
by: Tan, Cheng Siang.
Published: (2004)
Immunogenicity of soluble enterovirus 71 recombinant VP1 protein in mice model
by: Mustafa, Suhaili
Published: (2017)
by: Mustafa, Suhaili
Published: (2017)
A generic assay for whole-genome amplification and deep sequencingof enterovirus A71
by: Le, Van Tan, et al.
Published: (2015)
by: Le, Van Tan, et al.
Published: (2015)
A generic assay for whole-genome amplification and deep sequencing of enterovirus A71
by: Tan, Le Van, et al.
Published: (2015)
by: Tan, Le Van, et al.
Published: (2015)
A generic assay for whole-genome amplification and deep sequencing of enterovirus A71
by: Le Van, Tan, et al.
Published: (2015)
by: Le Van, Tan, et al.
Published: (2015)
Antiviral activity of silymarin in comparison with baicalein against EV-A71
by: Lalani, S.*, et al.
Published: (2020)
by: Lalani, S.*, et al.
Published: (2020)
Insights into innate and adaptive immune responses in vaccine development against EV-A71
by: Lim, Hui Xuan *, et al.
Published: (2019)
by: Lim, Hui Xuan *, et al.
Published: (2019)
Partial protection against enterovirus 71 (EV71) infection in a mouse model immunized with recombinant newcastle disease virus capsids displaying the EV71 VP1 fragment.
by: Wei, Choong Ch'ng, et al.
Published: (2011)
by: Wei, Choong Ch'ng, et al.
Published: (2011)
Characterization of the adaptive immune responses in enterovirus a71 infection / Aw Yong Kam Leng
by: Aw, Yong Kam Leng
Published: (2016)
by: Aw, Yong Kam Leng
Published: (2016)
Similar Items
-
Development of antivirals and vaccines against enterovirus 71 (EV-A71)
by: Poh, Chit Laa *
Published: (2018) -
Flavonoids as antiviral agents for Enterovirus A71 (EV-A71)
by: Lalani, S.*, et al.
Published: (2020) -
Development of novel vaccines against Enterovirus-71
by: Yee, Isabel Pin Tsin *, et al.
Published: (2015) -
Functional insights into Silymarin as an antiviral agent against Enterovirus A71 (EV-A71)
by: Lalani, S.*, et al.
Published: (2021) -
Molecular docking of SP40 peptide towards cellular
receptors for enterovirus 71 (EV-A71)
by: Masomian, Malihe *, et al.
Published: (2021)